In a patient with NIDDM which of the following condition is seen :
**Question:** In a patient with NIDDM (Non-Insulin Dependent Diabetes Mellitus), which of the following conditions is seen:
A. Increased insulin resistance
B. Decreased insulin secretion
C. Impaired glucose tolerance
D. Absence of insulin antibodies
**Core Concept:** Non-Insulin Dependent Diabetes Mellitus (NIDDM) is a type of diabetes mellitus where the body does not respond effectively to insulin, leading to hyperglycemia. This condition is primarily caused by insulin resistance, where the body's cells do not respond appropriately to insulin, resulting in increased glucose levels in the blood.
**Why the Correct Answer is Right:** In NIDDM, the primary problem is increased insulin resistance. This means that the body's cells become less responsive to insulin, making it difficult for glucose to enter cells and be utilized for energy production. As a result, the body produces more insulin in an attempt to overcome this resistance, leading to high blood glucose levels.
**Why Each Wrong Option is Incorrect:**
A. **Decreased insulin secretion:** This option is incorrect because NIDDM is primarily characterized by insulin resistance, not a decrease in insulin production. While insulin secretion may be affected in some patients, the main issue is the cells' resistance to insulin.
B. **Impaired glucose tolerance:** Impaired glucose tolerance (IGT) is a precursor to diabetes mellitus, usually seen in individuals who are predisposed to developing NIDDM. In NIDDM, IGT might be present, but it is not the primary cause.
C. **Absence of insulin antibodies:** Insulin antibodies are not relevant to NIDDM etiology. Insulin antibodies are usually associated with type 1 diabetes mellitus, where the body's immune system attacks and destroys insulin-producing beta cells in the pancreas. In NIDDM, the issue lies in insulin resistance, not the presence of insulin antibodies.
D. **Insulin antibodies:** This option is incorrect because insulin antibodies are more commonly associated with type 1 diabetes, where the immune system attacks and destroys insulin-producing beta cells in the pancreas. In NIDDM, the primary concern is insulin resistance, not the presence of insulin antibodies.
**Clinical Pearl:** Understanding the distinction between insulin resistance, decreased insulin secretion, impaired glucose tolerance, and insulin antibodies is crucial in accurately diagnosing and managing patients with NIDDM. Insulin resistance is the primary issue, and addressing this with oral hypoglycemic agents, lifestyle modifications, and sometimes insulin therapy can help improve blood glucose levels in patients with NIDDM.